Vor Biopharma VOR Stock
$21.41
1.229320%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$1.16B
LOW - HIGH [24H]
$20.17
-
$21.97
VOLUME [24H]
$851.75K
P/E Ratio
0
Earnings per share
-$70.40
ISIN
US9290332074
Vor Biopharma Price Chart
Vor Biopharma VOR Financial and Trading Overview
| Vor Biopharma stock price | 21.41 USD |
| Previous Close | 21.8 USD |
| Open | 21.51 USD |
| Bid | 15.2 USD x 200 |
| Ask | 26.36 USD x 200 |
| Day's Range | 20.48 - 21.72 USD |
| 52 Week Range | 6.5 - 50.2 USD |
| Volume | 905.01K USD |
| Avg. Volume | 1.19M USD |
| Market Cap | 1.15B USD |
| Beta (5Y Monthly) | 1.721 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -70.4 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 37.88 USD |
VOR Valuation Measures
| Enterprise Value | 657.45M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.6518006 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.924 |
Trading Information
Vor Biopharma Stock Price History
| Beta (5Y Monthly) | 1.721 |
| 52-Week Change | -49.88% |
| S&P500 52-Week Change | 18.32% |
| 52 Week High | 50.2 USD |
| 52 Week Low | 6.5 USD |
| 50-Day Moving Average | 16.75 USD |
| 200-Day Moving Average | 15.52 USD |
VOR Share Statistics
| Avg. Volume (3 month) | 1.19M USD |
| Avg. Daily Volume (10-Days) | 873.06K USD |
| Shares Outstanding | 54.19M |
| Float | 35.67M |
| Short Ratio | 3.86 |
| % Held by Insiders | 4.27% |
| % Held by Institutions | 75.28% |
| Shares Short | 7.29M |
| Short % of Float | 16.08% |
| Short % of Shares Outstanding | 13.45% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.75% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -341715008 USD |
| Net Income Avi to Common (ttm) | -883080000 USD |
| Diluted EPS (ttm) | -70.4 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 491.52M USD |
| Total Cash Per Share (mrq) | 9.07 USD |
| Total Debt (mrq) | 2.94M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 31.149 |
| Book Value Per Share (mrq) | -2.776 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -149892992 USD |
| Levered Free Cash Flow (ttm) | -188829120 USD |
Profile of Vor Biopharma
| Country | United States |
| State | MA |
| City | Boston |
| Address | 500 Boylston Street |
| ZIP | 02116 |
| Phone | 617 655 6580 |
| Website | https://www.vorbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 76 |
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Q&A For Vor Biopharma Stock
What is a current VOR stock price?
Vor Biopharma VOR stock price today per share is 21.41 USD.
How to purchase Vor Biopharma stock?
You can buy VOR shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vor Biopharma?
The stock symbol or ticker of Vor Biopharma is VOR.
Which industry does the Vor Biopharma company belong to?
The Vor Biopharma industry is Biotechnology.
How many shares does Vor Biopharma have in circulation?
The max supply of Vor Biopharma shares is 54.19M.
What is Vor Biopharma Price to Earnings Ratio (PE Ratio)?
Vor Biopharma PE Ratio is now.
What was Vor Biopharma earnings per share over the trailing 12 months (TTM)?
Vor Biopharma EPS is -70.4 USD over the trailing 12 months.
Which sector does the Vor Biopharma company belong to?
The Vor Biopharma sector is Healthcare.
Vor Biopharma VOR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25913.9 USD — |
+2.13
|
10.13B USD — | 25420.35 USD — | 25967.44 USD — | — - | 10.13B USD — |
|
US Tech Biotechnology
NBI
US
|
6431.2 USD — |
-0.34
|
— — | 6381.13 USD — | 6469.08 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1241.31 USD — |
+0.58
|
— — | 1233.81 USD — | 1244.91 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12723.95 USD — |
+2.13
|
— — | 12482.68 USD — | 12751.18 USD — | — - | — — |
- {{ link.label }} {{link}}
